Key result
Rapid ventricular pacing in dogs significantly increased plasma noradrenaline from 202 pg/mL at control to 750 pg/mL at 3 weeks, returning to baseline 4 weeks after pacing cessation.
During the development of pacing-induced heart failure in dogs, the rise in circulating noradrenaline involves dynamic changes in spill-over, uptake, and metabolism rather than just increased synthesis.
Answers are grounded in this paper and cite their sources.
Reversible noradrenaline rise in canine pacing model warrants no practice change; leaves open translation of sympathetic kinetics to human HF.
We have modified an assay utilizing ion-pair high-performance liquid chromatography with electrochemical detection to measure dihydroxyphenylalanine and dyhydroxyphenylglycol simultaneously with noradrenaline. We measured these agents at control, 1 and 3 weeks following the onset of rapid ventricular pacing, as well as 4 weeks after the cessation of a 3-week period of pacing. Our findings were as follows. Plasma noradrenaline increased significantly at 1 week and increased further after 3 weeks of pacing (control, 202 +/- 16; 1 week, 528 +/- 62; 3 weeks, 750 +/- 139 pg.mL-1). Plasma dihydroxyphenylalanine did not change throughout, while plasma dihydroxyphenylglycol was significantly elevated at 3 weeks (513 +/- 48 vs. 388 +/- 35 pg.mL-1 for the control). Four weeks after discontinuation of pacing, all parameters did not differ from the control. These results imply that during the development of heart failure, the rise in circulating noradrenaline does not reflect simply an increase in catecholamine synthesis, but that there are more dynamic changes associated with noradrenaline spill-over, uptake, and metabolism.
No takes yet. Share an insight, caveat, or question.
Förster et al. (1994) studied Pacing-induced heart failure. Rapid ventricular pacing vs. Control (baseline/unpaced state) was evaluated on Plasma noradrenaline levels. Rapid ventricular pacing in dogs significantly increased plasma noradrenaline from 202 pg/mL at control to 750 pg/mL at 3 weeks, returning to baseline 4 weeks after pacing cessation.
Synapse has enriched 10 related papers. Consider them for comparative context: